Zurich Cantonal Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $462K | Buy |
16,081
+1,389
| +9% | +$39.9K | ﹤0.01% | 1713 |
|
|
2025
Q1 | $493K | Sell |
14,692
-403
| -3% | -$13.5K | ﹤0.01% | 1607 |
|
|
2024
Q4 | $772K | Buy |
15,095
+2,970
| +24% | +$152K | ﹤0.01% | 1354 |
|
|
2024
Q3 | $620K | Sell |
12,125
-10
| -0.1% | -$511 | ﹤0.01% | 1425 |
|
|
2024
Q2 | $544K | Buy |
12,135
+2,952
| +32% | +$132K | ﹤0.01% | 1433 |
|
|
2024
Q1 | $430K | Buy |
9,183
+509
| +6% | +$23.8K | ﹤0.01% | 1570 |
|
|
2023
Q4 | $309K | Sell |
8,674
-1,515
| -15% | -$53.9K | ﹤0.01% | 1826 |
|
|
2023
Q3 | $303K | Hold |
10,189
| – | – | ﹤0.01% | 1694 |
|
|
2023
Q2 | $184K | Buy |
10,189
+2,321
| +29% | +$41.8K | ﹤0.01% | 1986 |
|
|
2023
Q1 | $126K | Buy |
7,868
+627
| +9% | +$10.1K | ﹤0.01% | 2158 |
|
|
2022
Q4 | $133K | Sell |
7,241
-164
| -2% | -$3K | ﹤0.01% | 2088 |
|
|
2022
Q3 | $145K | Hold |
7,405
| – | – | ﹤0.01% | 1955 |
|
|
2022
Q2 | $138K | Sell |
7,405
-88
| -1% | -$1.64K | ﹤0.01% | 2021 |
|
|
2022
Q1 | $164K | Buy |
7,493
+1,110
| +17% | +$24.3K | ﹤0.01% | 2015 |
|
|
2021
Q4 | $181K | Buy |
+6,383
| New | +$181K | ﹤0.01% | 2128 |
|